IN2009CN03512A - - Google Patents

Download PDF

Info

Publication number
IN2009CN03512A
IN2009CN03512A IN3512CHN2009A IN2009CN03512A IN 2009CN03512 A IN2009CN03512 A IN 2009CN03512A IN 3512CHN2009 A IN3512CHN2009 A IN 3512CHN2009A IN 2009CN03512 A IN2009CN03512 A IN 2009CN03512A
Authority
IN
India
Prior art keywords
flunixin
disclosed
preparation
transdermal
bovines
Prior art date
Application number
Other languages
English (en)
Inventor
Cheyney Meadows
Keith Alan Freehauf
Robert D Simmons
Allan J Weingarten
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Priority claimed from PCT/US2007/025808 external-priority patent/WO2008082507A2/en
Publication of IN2009CN03512A publication Critical patent/IN2009CN03512A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN3512CHN2009 2007-12-18 2007-12-18 IN2009CN03512A (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2007/025808 WO2008082507A2 (en) 2006-12-20 2007-12-18 Pharmaceutical compositions and method for treating inflammation in cattle and other animals
US87090709P 2009-12-20 2009-12-20

Publications (1)

Publication Number Publication Date
IN2009CN03512A true IN2009CN03512A (https=) 2015-08-14

Family

ID=54397675

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3512CHN2009 IN2009CN03512A (https=) 2007-12-18 2007-12-18

Country Status (1)

Country Link
IN (1) IN2009CN03512A (https=)

Similar Documents

Publication Publication Date Title
WO2008082507A3 (en) Pharmaceutical compositions and method for treating inflammation in cattle and other animals
PH12021551792A1 (en) Bi-ligand drug conjugate and use thereof
WO2008064192A3 (en) Modified release analgesic suspensions
BRPI0922789A2 (pt) peptídeo de ligação de albumina intermediador para reconhecimento de doença
CA2703234C (en) An inhalable dry powder formulation comprising glp-1 for use by pulmonary inhalation
WO2011014255A8 (en) Treatment of crohn's disease with laquinimod
EA200501420A1 (ru) Устройство доставки для лекарственной и клеточной терапии
TW200806318A (en) Uses of anti-insulin-like growth factor I receptor antibodies
EA200800161A1 (ru) Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций
EA201270144A1 (ru) Комбинированная терапия при лечении диабета
EA201491285A1 (ru) Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты
CY1121822T1 (el) Βραδεια ενδοκοιλιακη χορηγηση
WO2009004995A1 (ja) 生理活性物質を定着および発現させる方法
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
WO2014165607A3 (en) Aromatic-cationic peptide formulations, compositions and methods of use
WO2008109119A3 (en) Wnt compositions and methods of use thereof
CA2777746A1 (en) Benzoimidazole compounds and uses thereof
WO2007102090A3 (en) Topical formulation
WO2009003694A3 (en) Method for treating diseases related to mitochondrial dysfunction
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
MX341660B (es) Agonista del receptor de ghrelina para el tratamiento de caquexia.
BR112012020185A2 (pt) uso de preparações de heparina oral para tratar doenças e afecções do trato urinário.
RU2013157834A (ru) Композиции для подкожного введения физиологически активных средств
WO2012044783A8 (en) Method of achieving a thymosin beta 4 concentration in a human patient
MY166524A (en) Therapeutic substance, pharmaceutical composition, helicobacter pylori growth inhibitor and method for conducting anti-helicobacter therapy